rs149330798
Variant summary
Our verdict is Benign. Variant got -7 ACMG points: 2P and 9B. PM2BP4_StrongBP6BS1
The NM_004944.4(DNASE1L3):c.217G>A(p.Glu73Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000052 in 1,614,050 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_004944.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -7 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DNASE1L3 | NM_004944.4 | c.217G>A | p.Glu73Lys | missense_variant | 2/8 | ENST00000394549.7 | NP_004935.1 | |
DNASE1L3 | NM_001256560.2 | c.217G>A | p.Glu73Lys | missense_variant | 2/7 | NP_001243489.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DNASE1L3 | ENST00000394549.7 | c.217G>A | p.Glu73Lys | missense_variant | 2/8 | 1 | NM_004944.4 | ENSP00000378053 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000210 AC: 32AN: 152196Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000955 AC: 24AN: 251424Hom.: 0 AF XY: 0.0000589 AC XY: 8AN XY: 135888
GnomAD4 exome AF: 0.0000356 AC: 52AN: 1461736Hom.: 0 Cov.: 30 AF XY: 0.0000371 AC XY: 27AN XY: 727170
GnomAD4 genome AF: 0.000210 AC: 32AN: 152314Hom.: 0 Cov.: 32 AF XY: 0.000215 AC XY: 16AN XY: 74478
ClinVar
Submissions by phenotype
not provided Uncertain:1Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics | Jun 14, 2016 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Aug 20, 2022 | This sequence change replaces glutamic acid, which is acidic and polar, with lysine, which is basic and polar, at codon 73 of the DNASE1L3 protein (p.Glu73Lys). This variant is present in population databases (rs149330798, gnomAD 0.07%). This variant has not been reported in the literature in individuals affected with DNASE1L3-related conditions. ClinVar contains an entry for this variant (Variation ID: 377358). Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Tolerated"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0". The lysine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. Experimental studies have shown that this missense change does not substantially affect DNASE1L3 function (PMID: 24206041). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at